This podcast explores the confluences of forces behind two of the nation’s costliest specialties and the two leading causes of death: cancer and heart disease.
GDMT, or guideline-directed medical therapy, means taking the right medications at the optimal doses to treat cardiovascular problems. There's strong evidence that for many patients, GDMT is equivalent to, or better than, cardiovascular procedures, which are more costly. Yet these medications are chronically underused.
In this episode, we delve into this problem, the reasons for it and what might be done to improve the situation. NCH Senior Medical Director of Cardiology, Dr. Fernando Villacian, is joined by Dr. Nihar Desai, Associate Professor of Medicine and Associate Chief of the Section of Cardiovascular Medicine at Yale University School of Medicine, and Medical Director for Value Innovation at the Yale New Haven Health System, and Dr. Ileana Piña, Clinical Professor at Central Michigan University and past chair of the American Heart Association’s Council on Clinical Cardiology.
Every day, cardiologists make decisions about what is the most appropriate test, therapy, or procedure for their patients. But then COVID-19 came along. And the more we learned about how the virus wreaks havoc on the cardiovascular system, many of us started to wonder: Have the rules of the game changed?
In this episode, NCH Senior Medical Director of Cardiology Dr. Fernando Villacian discusses this important topic with two cardiologists who are not only treating individuals, but also reviewing clinical guidelines in response to COVID-19 and developing new policies in their hospitals: Dr. Nihar Desai, Associate Professor of Medicine and Associate Chief of the Section of Cardiovascular Medicine at Yale University School of Medicine and Medical Director for Value Innovation at the Yale New Haven Health System, and Dr. Ileana Piña, Clinical Professor at Central Michigan University and past chair of the American Heart Association’s Council on Clinical Cardiology.
From cytotoxic chemotherapy to targeted therapy: we’ve entered a new era of cancer care. What is life like as a provider in this new era? How can oncologists keep up with the latest science?
Dr. Vinay Prasad, Hematologist-Oncologist; Associate Professor of Medicine, University of California San Francisco; and best-selling author of Malignant: How Bad Policy and Bad Evidence Harm People with Cancer, and Dr. Andrew Hertler, Chief Medical Officer with New Century Health join us to explore this topic.
Palliative care—supportive care—is a glaring need in cancer care, but myths, misconceptions and mixed messages create barriers for broader palliative program implementation.
Dr. Vinay Prasad, Hematologist-Oncologist; Associate Professor of Medicine, University of California San Francisco; and best-selling author of Malignant: How Bad Policy and Bad Evidence Harm People with Cancer, and Dr. Andrew Hertler, Chief Medical Officer with New Century Health join us to explore this topic.
Choice paralysis. The therapeutic landscape in oncology is vast and everchanging, marked by a dramatic pace of innovation and new approvals. In this complicated specialty, how can payers and providers keep up to make decisions that maximize life for the patient?
Dr. Vinay Prasad, Hematologist-Oncologist; Associate Professor of Medicine, University of California San Francisco; and best-selling author of Malignant: How Bad Policy and Bad Evidence Harm People with Cancer, and Dr. Andrew Hertler, Chief Medical Officer with New Century Health join us to explore this complex topic.
There is tremendous excitement around the concept of precision oncology–that is, delivering therapies targeted to an individual patient’s specific type of cancer. But how many patients will truly benefit from these treatments? And do the results for these patients justify the hype?
In this episode, we cut through the hype to get precise about the promise of precision medicine. We're joined by Dr. Vinay Prasad, a Hematologist-Oncologist; Associate Professor of Medicine, University of California San Francisco; and best-selling author of Malignant: How Bad Policy and Bad Evidence Harm People with Cancer.
Welcome to Leading Causes, a podcast by New Century Health. In this series we explore the trends and forces behind the two leading causes of death in the United States: cancer and heart disease. Join us as we interview guest speakers, patient advocates and industry experts to dive deep into the confluence of forces at work behind these high-cost and complex specialties.